398 related articles for article (PubMed ID: 9501225)
1. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.
Conant K; Garzino-Demo A; Nath A; McArthur JC; Halliday W; Power C; Gallo RC; Major EO
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3117-21. PubMed ID: 9501225
[TBL] [Abstract][Full Text] [Related]
2. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis.
Eugenin EA; D'Aversa TG; Lopez L; Calderon TM; Berman JW
J Neurochem; 2003 Jun; 85(5):1299-311. PubMed ID: 12753088
[TBL] [Abstract][Full Text] [Related]
3. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.
D'Aversa TG; Yu KO; Berman JW
J Neurovirol; 2004 Apr; 10(2):86-97. PubMed ID: 15204927
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes.
Weiss JM; Nath A; Major EO; Berman JW
J Immunol; 1999 Sep; 163(5):2953-9. PubMed ID: 10453044
[TBL] [Abstract][Full Text] [Related]
5. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.
Kelder W; McArthur JC; Nance-Sproson T; McClernon D; Griffin DE
Ann Neurol; 1998 Nov; 44(5):831-5. PubMed ID: 9818943
[TBL] [Abstract][Full Text] [Related]
6. Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders.
Bonwetsch R; Croul S; Richardson MW; Lorenzana C; Del Valle L; Sverstiuk AE; Amini S; Morgello S; Khalili K; Rappaport J
J Neurovirol; 1999 Dec; 5(6):685-94. PubMed ID: 10602409
[TBL] [Abstract][Full Text] [Related]
7. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
El-Hage N; Gurwell JA; Singh IN; Knapp PE; Nath A; Hauser KF
Glia; 2005 Apr; 50(2):91-106. PubMed ID: 15630704
[TBL] [Abstract][Full Text] [Related]
8. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein.
Kim BO; Liu Y; Zhou BY; He JJ
J Immunol; 2004 Feb; 172(3):1888-95. PubMed ID: 14734774
[TBL] [Abstract][Full Text] [Related]
9. Chemokines and receptors in HIV encephalitis.
Sanders VJ; Pittman CA; White MG; Wang G; Wiley CA; Achim CL
AIDS; 1998 Jun; 12(9):1021-6. PubMed ID: 9662198
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.
El-Hage N; Wu G; Wang J; Ambati J; Knapp PE; Reed JL; Bruce-Keller AJ; Hauser KF
Glia; 2006 Jan; 53(2):132-46. PubMed ID: 16206161
[TBL] [Abstract][Full Text] [Related]
11. U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes.
Sheng WS; Hu S; Lokensgard JR; Peterson PK
Biochem Pharmacol; 2003 Jan; 65(1):9-14. PubMed ID: 12473373
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain.
Pu H; Tian J; Flora G; Lee YW; Nath A; Hennig B; Toborek M
Mol Cell Neurosci; 2003 Sep; 24(1):224-37. PubMed ID: 14550782
[TBL] [Abstract][Full Text] [Related]
13. Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.
Khiati A; Chaloin O; Muller S; Tardieu M; Horellou P
J Neurovirol; 2010 Mar; 16(2):150-67. PubMed ID: 20370601
[TBL] [Abstract][Full Text] [Related]
14. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.
Kolb SA; Sporer B; Lahrtz F; Koedel U; Pfister HW; Fontana A
J Neuroimmunol; 1999 Jan; 93(1-2):172-81. PubMed ID: 10378881
[TBL] [Abstract][Full Text] [Related]
15. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.
Sasseville VG; Smith MM; Mackay CR; Pauley DR; Mansfield KG; Ringler DJ; Lackner AA
Am J Pathol; 1996 Nov; 149(5):1459-67. PubMed ID: 8909235
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.
Schmidtmayerova H; Nottet HS; Nuovo G; Raabe T; Flanagan CR; Dubrovsky L; Gendelman HE; Cerami A; Bukrinsky M; Sherry B
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):700-4. PubMed ID: 8570619
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.
Eugenin EA; Dyer G; Calderon TM; Berman JW
Glia; 2005 Mar; 49(4):501-10. PubMed ID: 15578658
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases.
Conant K; St Hillaire C; Anderson C; Galey D; Wang J; Nath A
J Neurovirol; 2004 Feb; 10(1):21-8. PubMed ID: 14982725
[TBL] [Abstract][Full Text] [Related]
20. MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.
Eldeen MB; Deshmane SL; Simbiri K; Khalili K; Amini S; Sawaya BE
J Neuroimmunol; 2006 Jul; 176(1-2):174-80. PubMed ID: 16750572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
